.jpg?format=webp&width=780)
The U.S. Food and Drug Administration (FDA) warned against smartwatches and rings claiming noninvasive blood sugar measurement capabilities, stressing potential dangers. With roughly 37 million Americans having diabetes, inaccurate readings from such devices could lead to harmful consequences, including improper medication dosing and severe health complications. Despite ongoing efforts, noninvasive technologies for blood sugar measurement remain unreliable, urging consumers to rely on FDA-approved glucose monitoring systems for accurate results.
Like
Save
Share